Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The study design was a randomized, open‐label, two‐way, crossover, single‐dose,prospective, and longitudinal study, with a 7‐day wash‐out period before next dosing; tocompare the pharmacokinetic profile (Cmax, AUC0‐t and AUC0‐inf) of two 100 mg/1000 mgsitagliptin/metformin tablet in forty‐six (46) healthy male Mexican adult volunteers aged18 to 55 years.
Epistemonikos ID: 4ff54c1439f1159c2b1ea9265b5ab0d3ca087503
First added on: Aug 14, 2026